Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology
Open Access
- 23 October 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 13 (1), 497
- https://doi.org/10.1186/1471-2334-13-497
Abstract
Despite efforts to eliminate leprosy as public health problem, delayed diagnosis and disabilities still occur in many countries. Leprosy diagnosis remains based on clinical manifestations and the number of clinicians with expertise in leprosy diagnosis is in decline. We have developed a new immunochromatographic test with the goal of producing a simple and rapid system that can be used, with a minimal amount of training, to provide an objective and consistent diagnosis of multibacillary leprosy. The test immobilizes two antigens that have been recognized as excellent candidates for serologic diagnosis (the PGL-I mimetic, ND-O, and LID-1), on a nitrocellulose membrane. This allows the detection of specific IgM and IgG antibodies within 20 minutes of the addition of patient sera. Furthermore, we coupled the NDO-LID® rapid tests with a new cell phone-based test reader platform (Smart Reader®) to provide objective interpretation that was both quantifiable and consistent. Direct comparison of serologic responses indicated that the rapid test detected a greater proportion of leprosy patients than a lab-based PGL-I ELISA. While positive responses were detected by PGL-I ELISA in 83.3% of multibacillary patients and 15.4% of paucibacillary patients, these numbers were increased to 87% and 21.2%, respectively, when a combination of the NDO-LID® test and Smart Reader® was used. Among multibacillary leprosy the sensitivity of NDO-LID® test assessed by Smart Reader® was 87% (95% CI, 79.2-92.7%) and the specificity was 96.1% (95% CI, 91.7- 98.6%). The positive predictive value and the negative predictive value of NDO-LID® tests were 94% (95% CI, 87.4-97.8%) and 91.4% (95% CI, 85.9-95.2%), respectively. The widespread provision of rapid diagnostic tests to facilitate the diagnosis or prognosis of multibacillary leprosy could impact on leprosy control programs by aiding early detection, directing appropriate treatment and potentially interrupting Mycobacterium leprae transmission.Keywords
This publication has 41 references indexed in Scilit:
- Diagnosis and Treatment of Leprosy Reactions in Integrated Services - The Patients' Perspective in NepalPLoS Neglected Tropical Diseases, 2013
- Early Revelation of Leprosy in China by Sequential Antibody Analyses with LID-1 and PGL-IJournal of Tropical Medicine, 2013
- Impact of PGL-I Seropositivity on the Protective Effect of BCG Vaccination among Leprosy Contacts: A Cohort StudyPLoS Neglected Tropical Diseases, 2012
- Integrated rapid-diagnostic-test reader platform on a cellphoneLab on a Chip, 2012
- Insight toward Early Diagnosis of Leprosy through Analysis of the Developing Antibody Responses of Mycobacterium leprae -Infected ArmadillosClinical and Vaccine Immunology, 2011
- Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine developmentBMC Infectious Diseases, 2011
- The innate immune response in leprosyCurrent Opinion in Immunology, 2010
- Integration of Leprosy Elimination into Primary Health Care in Orissa, IndiaPLOS ONE, 2009
- Use of Protein Antigens for Early Serological Diagnosis of LeprosyClinical and Vaccine Immunology, 2007
- Prospective Study of Serological Conversion as a Risk Factor for Development of Leprosy among Household ContactsClinical and Vaccine Immunology, 2004